Yikon Genomics
About:
This company is a Genetic Tests To Support Family Planning Stages of Life.
Website: http://www.yikongenomics.com
Twitter/X: yikon_genomics
Top Investors: Oriza Holdings, Guangzhou Yuexiu Industrial Investment Fund, Sinopharm Capital, General Technology Venture Capital, Zhongjin Qide
Description:
Yikon Genomics is a leading solution-based single cell sequencing company. Currently based on the patented MALBAC® technology from Harvard University, Yikon provides complete solutions in the fields of reproductive health and cancer diagnostics with liquid tumor biopsy. The MALBAC-PGS™ and MALBAC-PGD™ solutions offer the most accurate and comprehensive embryo testing results for physicians to choose the best embryos with balanced chromosomal copy numbers,without inheriting the known disease-associated alleles. The MALBAC-PGS™ and MALBAC-PGD™ solutions have helped thousands of couples to achieve successful pregnancies. Yikon will continue to interpret the code of life and bring people the hope and joy of life.
$69.7M
$1M to $10M
Minhang, Shanghai, China
2012-01-01
nfo(AT)yikongenomics.com
Sunney Xie
51-100
2021-05-06
Private
© 2025 bioDAO.ai